These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
943 related articles for article (PubMed ID: 15242981)
1. Mesenchymal stem cells and their potential as cardiac therapeutics. Pittenger MF; Martin BJ Circ Res; 2004 Jul; 95(1):9-20. PubMed ID: 15242981 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Tang J; Xie Q; Pan G; Wang J; Wang M Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080 [TBL] [Abstract][Full Text] [Related]
3. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828 [TBL] [Abstract][Full Text] [Related]
4. Xenotransplantation of long-term-cultured swine bone marrow-derived mesenchymal stem cells. Nakamura Y; Wang X; Xu C; Asakura A; Yoshiyama M; From AH; Zhang J Stem Cells; 2007 Mar; 25(3):612-20. PubMed ID: 17095707 [TBL] [Abstract][Full Text] [Related]
7. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction. Nassiri SM; Khaki Z; Soleimani M; Ahmadi SH; Jahanzad I; Rabbani S; Sahebjam M; Ardalan FA; Fathollahi MS J Biomed Sci; 2007 Nov; 14(6):745-55. PubMed ID: 17605008 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction. Shyu KG; Wang BW; Hung HF; Chang CC; Shih DT J Biomed Sci; 2006 Jan; 13(1):47-58. PubMed ID: 16283432 [TBL] [Abstract][Full Text] [Related]
9. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. Zhang S; Ge J; Sun A; Xu D; Qian J; Lin J; Zhao Y; Hu H; Li Y; Wang K; Zou Y J Cell Biochem; 2006 Nov; 99(4):1132-47. PubMed ID: 16795039 [TBL] [Abstract][Full Text] [Related]
10. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Hou M; Yang KM; Zhang H; Zhu WQ; Duan FJ; Wang H; Song YH; Wei YJ; Hu SS Int J Cardiol; 2007 Feb; 115(2):220-8. PubMed ID: 16889848 [TBL] [Abstract][Full Text] [Related]
11. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts. Qian HY; Yang YJ; Huang J; Gao RL; Dou KF; Yang GS; Li JJ; Shen R; He ZX; Lu MJ; Zhao SH Chin Med J (Engl); 2007 Aug; 120(16):1416-25. PubMed ID: 17825171 [TBL] [Abstract][Full Text] [Related]
12. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Mauney JR; Volloch V; Kaplan DL Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Dai W; Hale SL; Martin BJ; Kuang JQ; Dow JS; Wold LE; Kloner RA Circulation; 2005 Jul; 112(2):214-23. PubMed ID: 15998673 [TBL] [Abstract][Full Text] [Related]
14. In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice. Chou SH; Kuo TK; Liu M; Lee OK J Orthop Res; 2006 Mar; 24(3):301-12. PubMed ID: 16482576 [TBL] [Abstract][Full Text] [Related]
15. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Chen MY; Lie PC; Li ZL; Wei X Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653 [TBL] [Abstract][Full Text] [Related]
16. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [TBL] [Abstract][Full Text] [Related]
17. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Boomsma RA; Swaminathan PD; Geenen DL Int J Cardiol; 2007 Oct; 122(1):17-28. PubMed ID: 17187879 [TBL] [Abstract][Full Text] [Related]
18. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Poncelet AJ; Vercruysse J; Saliez A; Gianello P Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713 [TBL] [Abstract][Full Text] [Related]
19. Trafficking and differentiation of mesenchymal stem cells. Liu ZJ; Zhuge Y; Velazquez OC J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871 [TBL] [Abstract][Full Text] [Related]